Las Vegas, NV -- (SBWIRE) -- 10/15/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Coronado Biosciences Inc (NASDAQ:CNDO), Fab Universal Corp (NYSEMKT:FU), Cereplast Inc (OTCMKTS:CERP), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
Coronado Biosciences Inc (NASDAQ:CNDO) managed to keep its fall at -66.90% on traded volume of 26.25 million shares. The stock settled at $1.91 after floating in a range of $1.73 to $2.16. After recent close, it has reached market capitalization of $64.83 million. Its 52-week range has been $1.73 to $12.70. Coronado Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.
Will CNDO Get Buyers Even After The Recent Rally? Find Out Here
Fab Universal Corp (NYSEMKT:FU) traded up on a volume of 10.64 million, higher than its standard daily volume. Shares have gained 37.08% to $6.95. Over the last twelve months the stock has added 63.92% and faced a worst price of $5.46. FAB Universal Corp. engages in the distribution of digital entertainment products and services worldwide. The company operates in three segments: Wholesale, Retail, and Kiosk/Licensing.
Will FU Continue To Move Higher? Find Out Here
Cereplast Inc (OTCMKTS:CERP) settled -2.00% lower at $0.0147 on traded volume of 9.41 million shares during the last trading day, while its average trading volume remained 11.78 million shares. The stock has its 12-month low at $0.01 and 52-week high price was $0.28. It traded in a range of $0.01 to $0.01 during the last trading day. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
Will CERP Get Buyers Even After The Recent Rally? Find Out Here
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) saw its price gain on traded volume as 8.56 million shares changed hands when compared with its average daily volume of 3.80 million shares. The stock was up 7.52% to $2.86. It has fallen over the last 12 months, dropping -73.49% and marked new low $2.40. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.
Will ACHN Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)